Bayer, CureVac part ways on COVID-19 vaccine: reports jkeenan Fri, 10/15/2021 – 10:43 More: Bayer, CureVac part ways on COVID-19 vaccine: reports Source: fierce
read moreDespite Merck’s oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales ahead: analyst aliu Fri, 10/15/2021 – 10:08 More: Despite Merck's oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales
read moreJohnson & Johnson puts talc headache into bankruptcy; plaintiffs will contest the ploy kdunleavy Fri, 10/15/2021 – 09:02 More: Johnson & Johnson puts talc headache into bankruptcy; plaintiffs will contest the ploy Source: fierce
read moreUnder the terms of the agreement, Hansoh will make a $16m upfront payment to Silence More: Silence Therapeutics announces siRNA collaboration with Hansoh Pharma Source: News
read moreSensyne and OMNY have agreed to work together on commercial projects for life sciences clients to advance ethical medical research More: Sensyne Health and OMNY Health sign agreement to support AI research Source: News
read moreThere are around 200 people in England who are eligible for this treatment More: NICE clears Opdivo for resected oesophageal or gastro-oesophageal junction cancer Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals